【Nagoya Nishi Ward】'Metalo-Balance Test' for Cancer and Cognitive Risk Assessment with Just 6mL Blood Draw Launches at Naomi Family Clinic Nagoya Ogata on July 28, 2026

Renatech Inc. (Headquarters: Isehara City, Kanagawa Prefecture), a company that develops health indicators based on trace elements and applies them to real-world settings, is pleased to announce the launch of its proprietary screening test, the 'Metalo-Balance Test,' which assesses the risk of cancer and MCI (Mild Cognitive Impairment), at Naomi Family Clinic Nagoya Ogata (Nishi Ward, Nagoya City, Aichi Prefecture) starting Tuesday, July 28, 2026.

With the addition of this clinic, the testing infrastructure for the 'Metalo-Balance Test' in Nagoya's Nishi Ward and surrounding areas will be further strengthened, providing local residents with easier access to a new and convenient health management option.

Renatech will continue to expand partnerships with medical institutions nationwide, aiming to encourage more people to take interest in their health and reconsider their daily health habits and lifestyles as part of preventive care.

What is the Metalo-Balance (MB) Test?

The Metalo-Balance Test is a risk screening (triage) test that objectively evaluates the risk of cancer and MCI (Mild Cognitive Impairment) at the time of blood draw by analyzing the concentration balance of 17 trace elements (metallic elements) in the blood.

### Key Features of the Test

- Only one 6mL blood draw: Blood is safely collected under the proper management of medical institutions. The test takes approximately 15 minutes, minimizing physical burden and ensuring safety.

- Site-specific 'Cancer Risk Test': With a single blood draw, cancer risks are evaluated by body site (6 sites for men, 9 for women) and scored on a four-tier scale from A to D. - [Men] Lung cancer, stomach cancer, liver cancer, pancreatic cancer, colorectal cancer, prostate cancer - [Women] Lung cancer, stomach cancer, liver cancer, pancreatic cancer, colorectal cancer, breast cancer, cervical cancer, endometrial cancer, ovarian cancer

- Comprehensive 'Cognitive Risk Test (MCI Risk Assessment)': Evaluates all types of MCI, including Alzheimer's type, vascular type, and Lewy body type.

- Proven research results and international recognition: Developed through joint research with Kanagawa Prefectural Cancer Center and Chiba Prefectural Cancer Center, supported by a research grant from the Ministry of Economy, Trade and Industry's Go-Tech program. Patented in 9 countries including Japan, with over 100,000 individuals tested cumulatively (from April 2019 to March 2026).

Testing Process and Key Precautions

※ Due to the need for document mailing procedures, advance registration is required approximately three weeks before your desired testing date (by complete reservation system).

- Application: Apply via website or phone. A complete set of test documents will be delivered to your home about one week before your appointment.

- Test Day (Blood Draw): As the test is fully reservation-based, blood collection proceeds smoothly (takes about 15 minutes). Payment is via convenience store post-payment, so no on-site payment is required.

- Results Notification: Your invoice (payment slip) will be mailed to your home approximately three weeks after blood draw, and your test results approximately five weeks after.

### Key Precautions Before Testing

- Food and alcohol: No food after 9 PM the previous day. No alcohol consumption the day before. - Hydration: Drink plenty of water to make blood draw easier. - Medications and supplements: Do not take over-the-counter medicines or supplements the day before. Continue taking prescribed medications as usual.

Test Fees (Private Pay)

This test is not covered by health insurance and is offered as a private-pay service. Choose from the following plans based on your needs:

- Cancer Risk Test: ¥19,800 (tax included) - Cognitive Risk Test: ¥19,800 (tax included) - Cancer and Cognitive Risk Test Set: ¥24,200 (tax included)

※ Payment will be via 'convenience store post-payment' sent to your home after blood draw.

Eligibility and Important Notes for the Metalo-Balance Test

### Age Eligibility

- Cancer Risk Test: Japanese nationals aged 20 to 80 - Cognitive Risk Test: Japanese nationals aged 50 to 80

※ As this test was developed based on data from Japanese individuals within the above age ranges, those outside this range or non-Japanese nationals may still take the test, but results will be considered 'reference values' only. Please understand this in advance.

### Individuals Who Cannot Take the Test

- Pregnant individuals or those within 6 months postpartum - Individuals currently undergoing cancer treatment or within one year of completing treatment - Individuals undergoing dialysis - Individuals with fractures, blood disorders, or immunodeficiency (excluding lipid disorders such as high triglycerides) - Individuals feeling unwell (due to lack of sleep, after an all-nighter, immediately after intense exercise, under severe stress, or with symptoms such as cold, asthma, shingles, allergic rash, or rhinitis)

Overview of the Newly Partnered Medical Institution

- Test Start Date: Tuesday, July 28, 2026 - Test Days and Hours: Tuesday, Wednesday, Friday, Saturday (excluding holidays and clinic closure days)

- Medical Institution Name: Naomi Family Clinic Nagoya Ogata - Address: 2F Tsuruha Drug Store, 3-17 Ogata, Nishi Ward, Nagoya City, 452-0822, Aichi Prefecture 📍MAP - Access: 14-minute walk from Meitetsu Inuyama Line Ogata Station / 20-minute walk from Tokai Transport Service Seibu Line Owari Hoshinomiya Station / 21-minute walk from Meitetsu Inuyama Line Kamiohata Station - Available Tests: Cancer Risk Test, Cognitive Risk Test

⚠️ Important Request Regarding Testing (Please Read Carefully)

- Please refrain from contacting the medical institution directly: The hospital front desk or phone line cannot handle inquiries or applications for this test. All questions and applications regarding the test must be directed to Renatech.

- For more details and to apply, please visit:

- Metalo-Balance Test Information Site: https://www.mbkensa.com/

- Dedicated Toll-Free Number: 0120-785-602 (Renatech: Weekdays 9:00–17:00)

▼ Digital Version of the Metalo-Balance Test Brochure

🏥 Partner medical institutions nationwide are also being recruited! For information on introducing the Metalo-Balance Test, click here.

Metalona-chan, the official character of Metalo-Balance

Renatech Inc. is an innovative company that develops proprietary technologies in the medical and health fields, aiming to assess early risks of diseases such as cancer, as well as in environmental fields. The company has been selected as one of the '300 Outstanding SMEs and Small Businesses' by the Ministry of Economy, Trade and Industry and the Small and Medium Enterprise Agency, recognizing its advanced technological capabilities and social contributions.

Among its offerings, the 'Metalo-Balance Test' has gained significant attention as a groundbreaking screening technology that evaluates cancer and MCI (Mild Cognitive Impairment) risks by analyzing the concentration of 17 trace elements in the blood. Moving forward, the company will continue to create new value to enhance public health and address societal challenges based on its advanced technological expertise.

Company Overview

- Company Name: Renatech Inc. - Representative: Kei Kato, CEO - Headquarters: 4-19-15 Takamori, Isehara City, Kanagawa Prefecture 259-1114 - URL: https://www.renatech.net/